Romosozumab was not effective in preventing multiple spontaneous clinical vertebral fractures after denosumab discontinuation: A case report

Discontinuation of denosumab is associated with the increase of bone turnover markers to above-baseline levels (so-called rebound in bone turnover) and rapid bone loss. Several studies have reported vertebral fractures (VFs), particularly multiple spontaneous clinical VFs (MSCVFs), occurring after d...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Masafumi Kashii, Kosuke Ebina, Kazuma Kitaguchi, Hideki Yoshikawa
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2020-12-01
coleção:	Bone Reports
Assuntos:	Denosumab Romosozumab Vertebral fractures Discontinuation
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2352187220300486
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!